Skip to content

Bard® InLay® Ureteral Stent 778722Recalls & reported problems

C. R. Bard, Inc. · INLAY URETERAL STENT w/o GUIDEWIRE · Class 2 · Implant

All models of Bard InLay Ureteral Stent (11)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741014888), received between Jun 27, 2022 and Jun 27, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Handling Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Handling Problem1
  • Expiration Date Error1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 27, 2022Expiration Date Error; Device Handling Problem; Expiration Date Error; Device Handling Problem

    IT WAS REPORTED THAT THE CUSTOMER WAS ADVISED THAT THEY UTILIZED A STENT ON A PATIENT AND IT HAD EXPIRED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14830070 ↗

Other STENT, URETERAL devices

All STENT, URETERAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page